The latest market report published by Credence Research, Inc. “Global Molecular Diagnostics Market – Market Growth, Future Prospects, Competitive Analysis, 2017 – 2025,” the global molecular diagnostics market was valued at US$ 6,077.9 Mn in 2016, and is expected to reach US$ 12,358.6 Mn by 2025 expanding at a CAGR of 7.8 % from 2017 to 2025.
Browse the full report Global Molecular Diagnostics Market – Market Growth, Future Prospects, Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/molecular-diagnostic-market
Molecular diagnostics has undergone tremendous technological advancement due to the growing need for personalized medication, rapid diagnosis to determine antibiotic regimen in order to prevent drug resistance and for the in-depth study of pandemic diseases such as Cholera, Swine flu, Dengue and Hepatitis A. In 2016, the reagents and kits held the largest revenue share for the product segment due to factors such as increasing number of clinics and laboratories performing diagnosis, rising public awareness leading to early disease diagnosis and treatment, and government initiatives to promote public health and welfare. Instruments will be the fastest growing segment among the considered products throughout the forecast period 2017-2025 as they are undergoing tremendous modifications corresponding to specific requirements and inbuilt applications make it easy for the skilled workforce to perform accurate diagnosis in lesser span of time.
Furthermore, this report concludes with profiling of key players currently enjoying prominent position in the global molecular diagnostics market. The key players profiled in this report are Abbott Laboratories, Inc., Alere, Inc., Bayer AG, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffman La-Roche Ltd., Novartis AG, Qiagen N.V., Siemens Healthcare, and Sysmex Corporation.
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Molecular Diagnostics Market Portraiture
2.1.1. Global Molecular Diagnostics Market, by Product, 2016
2.1.2. Global Molecular Diagnostics Market, by Technology, 2016
2.1.3. Global Molecular Diagnostics Market, by Application, 2016
2.1.4. Global Molecular Diagnostics Market, by Geography, 2016
Chapter 3. Molecular Diagnostics Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Prevalence Data of Major Target Diseases (Cholera, Malaria, Coronary Artery Disease, Diabetes, ESRD, & Chronic Kidney Diseases etc.)
3.6. Porter’s Five Forces Analysis …
Chapter 8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Alere, Inc.
8.3. Bayer AG
8.4. Becton Dickinson and Company
8.5. BioMerieux SA …
Request for customization research report @ http://www.credenceresearch.com/request-for-customization/58588
Based on product, the global molecular diagnostics market is categorized into
- Reagents and Kits
- Services and Software
Diverse reagents and kits such as acetonitrile, methane, Baeyer’s reagent, carbon disulfide, Brdu ELISA kit, typhoid kit, hepatitis B detection kit etc. are available to perform clinical and molecular diagnosis of diseases. Sophisticated instruments such as high performance liquid chromatography (HPLC), mass spectrometry, gas chromatography and nuclear magnetic resonance (NMR) are employed to identify and detect various pathogens and other biopsy parameters present in the samples obtained from patients suffering with different ailment. Software that are utilized in these instruments are undergoing rapid transition in order to meet the requirement of accurate, precise and reliable data analysis and interpretation of the disease under investigation.
Download sample research report @ http://www.credenceresearch.com/sample-request/58588
Based on application areas, the global molecular diagnostics market is categorized into
- Infectious Diseases
- Next Generation Sequencing
- DNA Sequencing
Molecular diagnostics is utilized for identification of biological markers in the human genome in order to identify gene expression respective to diseases. It is very vital in the early diagnosis of life threatening diseases where effective treatment regimen is considered immediately. Emergence of infectious diseases such as from Ebola virus and Zika virus, where early disease etiology and symptoms are difficult to detect and interpret, drives the need for molecular diagnosis. Molecular diagnostics helps to decide treatment regimen in accordance to the nature of disease and patients.
Related Reports :
Company Name: Credence Research, Inc
Contact Person: Chris Smith, Global Sales Manager
Email: Send Email
Address:105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
Country: United States